Iridex (IRIX) Acquisitions (2011 - 2022)

Iridex (IRIX) posted Acquisitions of -$5.3 million for Q3 2022, down 200.0% on a QoQ basis from $5.3 million in Q2 2021.

Analysis

Iridex (IRIX) Acquisitions (2011 - 2022) Analysis & Trends

Iridex has reported Acquisitions for 3 years, with the latest figure at -$5.3 million in Q3 2022.

On a quarterly basis, Acquisitions changed N/A year-over-year to -$5.3 million in Q3 2022; TTM through Apr 2021 was $5.4 million, a N/A change from a year earlier, with the FY2022 full-year figure at $5.3 million, changed N/A from the prior year.
Acquisitions was -$5.3 million for Q3 2022 at Iridex, down from $5.3 million in the prior quarter.
The five-year high for Acquisitions was $5.3 million in Q2 2021, with the low at -$5.3 million in Q3 2022.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	-
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	1.16 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	437.00 Mn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	195.00 Mn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	-
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	-
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	16.00 Mn
10	Iridex	11.85 Mn	7.17 Mn	4.30 Mn	-

Historic Data

Download Data